TARSUS PHARMACEUTICALS INC (TARS) Institutional Ownership Changes & 13F Activity
TARSUS PHARMACEUTICALS INC (TARS). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Rtw Investments, Lp, Paradigm Biocapital Advisors Lp, Janus Henderson Group Plc, Tang Capital Management Llc, and Driehaus Capital Management Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Ensign Peak Advisors, Inc | Sell | -8,314 | -1.7% | 474,050 | $38.82M | Q4 2025 | Aug 18, 2026 |
| Algert Global Llc | Buy | +45,985 | — | 45,985 | $3.77M | Q4 2025 | Aug 11, 2026 |
| Seven Fleet Capital Management Lp | Buy | +4,500 | — | 4,500 | $368.46K | Q4 2025 | Feb 26, 2026 |
| Bell Investment Advisors, Inc | Buy | +11 | — | 11 | $901.00 | Q4 2025 | Feb 24, 2026 |
| Raymond James Financial Inc | Buy | +35,649 | — | 35,649 | $2.92M | Q4 2025 | Feb 18, 2026 |
| Ikarian Capital, Llc | Buy | +31,166 | — | 31,166 | $2.55M | Q4 2025 | Feb 18, 2026 |
| Mackenzie Financial Corp | Buy | +2,454 | — | 2,454 | $201.64K | Q4 2025 | Feb 18, 2026 |
| Rtw Investments, Lp | Buy | +3,335,320 | — | 3,335,320 | $273.10M | Q4 2025 | Feb 17, 2026 |
| Paradigm Biocapital Advisors Lp | Buy | +2,562,154 | — | 2,562,154 | $209.79M | Q4 2025 | Feb 17, 2026 |
| Janus Henderson Group Plc | Buy | +1,930,325 | — | 1,930,325 | $158.06M | Q4 2025 | Feb 17, 2026 |
| Tang Capital Management Llc | Buy | +1,188,624 | — | 1,188,624 | $97.32M | Q4 2025 | Feb 17, 2026 |
| Driehaus Capital Management Llc | Buy | +1,172,427 | — | 1,172,427 | $96.00M | Q4 2025 | Feb 17, 2026 |
| Bank Of America Corp | Buy | +758,106 | — | 758,106 | $62.07M | Q4 2025 | Feb 17, 2026 |
| Fmr Llc | Buy | +647,114 | — | 647,114 | $52.99M | Q4 2025 | Feb 17, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +615,156 | — | 615,156 | $50.37M | Q4 2025 | Feb 17, 2026 |
| Nomura Asset Management International Inc. | Buy | +584,686 | — | 584,686 | $47.87M | Q4 2025 | Feb 17, 2026 |
| Price T Rowe Associates Inc | Buy | +518,780 | — | 518,780 | $42.48M | Q4 2025 | Feb 17, 2026 |
| Toronto Dominion Bank | Buy | +510,253 | — | 510,253 | $41.78M | Q4 2025 | Feb 17, 2026 |
| Artisan Partners Limited Partnership | Buy | +436,576 | — | 436,576 | $35.75M | Q4 2025 | Feb 17, 2026 |
| Qube Research & Technologies Ltd | Buy | +401,241 | — | 401,241 | $32.85M | Q4 2025 | Feb 17, 2026 |
| Northern Trust Corp | Buy | +342,486 | — | 342,486 | $28.04M | Q4 2025 | Feb 17, 2026 |
| Mpm Bioimpact Llc | Buy | +328,869 | — | 328,869 | $26.93M | Q4 2025 | Feb 17, 2026 |
| Rock Springs Capital Management Lp | Buy | +260,344 | — | 260,344 | $21.32M | Q4 2025 | Feb 17, 2026 |
| Cormorant Asset Management, Lp | Buy | +250,000 | — | 250,000 | $20.47M | Q4 2025 | Feb 17, 2026 |
| Integral Health Asset Management, Llc | Buy | +200,000 | — | 200,000 | $16.38M | Q4 2025 | Feb 17, 2026 |
| Orbimed Advisors Llc | Buy | +154,400 | — | 154,400 | $12.64M | Q4 2025 | Feb 17, 2026 |
| Russell Investments Group, Ltd. | Buy | +153,760 | — | 153,760 | $12.59M | Q4 2025 | Feb 17, 2026 |
| Canada Pension Plan Investment Board | Buy | +151,100 | — | 151,100 | $12.37M | Q4 2025 | Feb 17, 2026 |
| Jump Financial, Llc | Buy | +128,087 | — | 128,087 | $10.49M | Q4 2025 | Feb 17, 2026 |
| Millennium Management Llc | Buy | +117,004 | — | 117,004 | $9.58M | Q4 2025 | Feb 17, 2026 |
Frequently asked questions about TARS activity
Which institutional owners are buying TARS?
Institutional owners buying TARS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in TARS activity?
"Buy" means an investor increased their reported position in TARS compared to the prior reporting period. This reflects growing exposure to TARSUS PHARMACEUTICALS INC (TARS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in TARS increasing?
Institutional interest in TARS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related TARS Institutional Insights
- TARS Overview
- TARS 13F Institutional Holders
- TARS Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- TARS Insider Trading & SEC Form 4 Activity
- TARS Articles
- Top Institutional Investor Stock Rankings